Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Company
>>
Novartis hypertension drug gets Chinese approval
>> article
Novartis hypertension drug gets Chinese approval
Editor:lizz Clicks:
0
Date:2010-7-21 14:44:42
Keyword:
Novartis Rasilez Tekturna aliskiren
Healthoo Information:
Novartis Pharma high blood pressure medicine Rasilez Receives Chinese Approval.
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Market share of different Valsartan brands
Novartis stable development in China in ...
Novartis gets 85% stake of Zhejiang Tian...
Huahai and Novartis signed the agreement ...
Novartis Jiangsu API base put into opera...
Novartis to buy majority stake of Zhejia...
Novartis to invest Times="10".25 bn on China&nbs...
The third largest research centre settled&nbs...
Novartis aiming to expand OTC Business i...
Sandoz purchased a Chinese pharmaceutical fac...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
